关于 Relugolix
- 原研厂家
- Takeda Yakuhin Kogyo Co.,Ltd
- 适应症
- Prostate Cancer; Leiomyoma
- 获批日期
- 12/18/2020
- NCE 专利
- 12/18/2025
- DS/DP
- 01/28/2026
可供应中间体
当前列出 Relugolix 的 7 个中间体。可就下方任一产品索取规格、文件或报价。
| 产品名称 | CAS 号 | 分子式 | 物理性质 |
|---|---|---|---|
| 2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylic acid | 1589503-95-6 | / | / |
| 3-AMINO-6-METHOXYPYRIDAZINE | 7252-84-8 | / | / |
| ethyl 2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate | 308831-94-9 | / | / |
| 2-AcetaMido-4,5-diMethylthiophene-3-carboxylic acid | 2591260-09-0 | / | / |
| 3-Thiophenecarboxylic acid, 2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-4-[(dimethylamino)methyl]-5-(4-nitrophenyl)-, ethyl ester | 2591260-08-9 | / | / |
| 3-Thiophenecarboxylic acid,5-(4-aminophenyl)-2-[[(2,6-difluorophenyl)methyl](ethoxycarbonyl)amino]-4-[(dimethylamino)methyl]-,ethylester, hydrochloride (1:2) | 2768834-98-4 | / | / |
| 2-[(2,6-Difluorobenzyl)ethoxycarbonylamino]-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylic acid ethyl ester | 1589503-97-8 | / | / |
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →